BlackRock’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.02M | Hold |
|
|||||
|
2025
Q2 | $305K | Sell |
|
|||||
|
2025
Q1 | $153K | Sell |
|
|||||
|
2024
Q4 | $309K | Buy |
|
|||||
|
2024
Q3 | $1.84M | Sell |
|
|||||
|
2024
Q2 | $1.72M | Sell |
|
|||||
|
2024
Q1 | $2.69M | Buy |
|
|||||
|
2023
Q4 | $2.37M | Sell |
|
|||||
|
2023
Q3 | $1.72M | Sell |
|
|||||
|
2023
Q2 | $1.49M | Sell |
|
|||||
|
2023
Q1 | $4.15M | Sell |
|
|||||
|
2022
Q4 | $6.5M | Sell |
|
|||||
|
2022
Q3 | $79.7M | Buy |
|
|||||
|
2022
Q2 | $40.9M | Buy |
|
|||||
|
2022
Q1 | $52.7M | Buy |
|
|||||
|
2021
Q4 | $31.2M | Buy |
|
|||||
|
2021
Q3 | $31.7M | Sell |
|
|||||
|
2021
Q2 | $47.1M | Sell |
|
|||||
|
2021
Q1 | $52.4M | Sell |
|
|||||
|
2020
Q4 | $47.9M | Buy |
|
|||||
|
2020
Q3 | $45.6M | Sell |
|
|||||
|
2020
Q2 | $54.4M | Buy |
|
|||||
|
2020
Q1 | $16.3M | Buy |
|
|||||
|
2019
Q4 | $5.58M | Buy |
|